Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy.

Marks KM, Clarke RM, Bussel JB, Talal AH, Glesby MJ.

J Acquir Immune Defic Syndr. 2009 Dec;52(5):595-9. doi: 10.1097/QAI.0b013e3181b79aff.

2.

Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas.

Firnhaber C, Smeaton L, Saukila N, Flanigan T, Gangakhedkar R, Kumwenda J, La Rosa A, Kumarasamy N, De Gruttola V, Hakim JG, Campbell TB.

Int J Infect Dis. 2010 Dec;14(12):e1088-92. doi: 10.1016/j.ijid.2010.08.002. Epub 2010 Oct 18.

3.
4.

Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors.

Carbonara S, Fiorentino G, Serio G, Maggi P, Ingravallo G, Monno L, Bruno F, Coppola S, Pastore G, Angarano G.

J Infect. 2001 May;42(4):251-6.

PMID:
11545567
5.

Incidence and risk factors of thrombocytopenia in patients receiving intermittent antiretroviral therapy: a substudy of the ANRS 106-window trial.

Bouldouyre MA, Charreau I, Marchou B, Tangre P, Katlama C, Morlat P, Meiffredy V, Vittecoq D, Bierling P, Aboulker JP, Molina JM; ANRS 106 Study Group..

J Acquir Immune Defic Syndr. 2009 Dec;52(5):531-7. doi: 10.1097/QAI.0b013e3181be73e3.

PMID:
19855285
6.

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, Battegay M, Vernazza P, Bernasconi E, Opravil M, Kaufmann D, Sudre P, Francioli P, Telenti A.

JAMA. 1999 Dec 15;282(23):2220-6.

PMID:
10605973
7.

The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction.

Towner WJ, Xu L, Leyden WA, Horberg MA, Chao CR, Tang B, Klein DB, Hurley LB, Quesenberry CP Jr, Silverberg MJ.

J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):321-7. doi: 10.1097/QAI.0b013e31824e9ef2.

8.

Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy.

Yacisin K, Maida I, Ríos MJ, Soriano V, Núñez M.

AIDS Res Hum Retroviruses. 2008 Jul;24(7):935-40. doi: 10.1089/aid.2008.0069.

PMID:
18593347
9.

Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.

Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD; HepaI.Co.N.A. Study Group.; Italian Cohort Naive for Antiretrovirals Study Group..

Clin Infect Dis. 2005 Jun 15;40(12):e101-9. Epub 2005 May 5.

PMID:
15909251
10.

Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.

Bonnet F, Morlat P, Chêne G, Mercié P, Neau D, Chossat I, Decoin M, Djossou F, Beylot J, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)..

HIV Med. 2002 Jul;3(3):195-9.

11.

Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV/HCV coinfection.

Ioannou GN, Bryson CL, Weiss NS, Boyko EJ.

Eur J Gastroenterol Hepatol. 2015 May;27(5):577-84. doi: 10.1097/MEG.0000000000000290.

PMID:
25769096
12.

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J; EuroSIDA Study Group..

J Infect Dis. 2005 Sep 15;192(6):992-1002. Epub 2005 Aug 11.

PMID:
16107951
13.

Hepatitis C and progression of HIV disease.

Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL.

JAMA. 2002 Jul 10;288(2):199-206.

PMID:
12095384
14.

Longer duration of HBV-active antiretroviral therapy is linked to favorable virological outcome in HIV-HBV co-infected patients.

Lee T, Núñez M.

HIV Clin Trials. 2009 May-Jun;10(3):153-9. doi: 10.1310/hct1003-153.

PMID:
19632954
15.

Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.

Giordano TP, Kramer JR, Souchek J, Richardson P, El-Serag HB.

Arch Intern Med. 2004 Nov 22;164(21):2349-54.

PMID:
15557414
16.

Surveillance for thrombocytopenia in persons infected with HIV: results from the multistate Adult and Adolescent Spectrum of Disease Project.

Sullivan PS, Hanson DL, Chu SY, Jones JL, Ciesielski CA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Apr 1;14(4):374-9. Erratum in: J Acquir Immune Defic Syndr Hum Retrovirol 1997 May 1;15(1):94.

PMID:
9111481
17.

Outcomes in HIV/HBV-Coinfected Patients in the Tenofovir Era Are Greatly Affected by Immune Suppression.

Huang AJ, Núñez M.

J Int Assoc Provid AIDS Care. 2015 Jul-Aug;14(4):360-8. doi: 10.1177/2325957415586258. Epub 2015 May 21.

PMID:
25999329
18.

Changes in the incidence of severe thrombocytopenia and its predisposing conditions in HIV-infected patients since the introduction of highly active antiretroviral therapy.

Franzetti M, Adorni F, Oreni L, Van Den Bogaart L, Resnati C, Milazzo L, Antinori S, Galli M, Ridolfo AL.

J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):493-8. doi: 10.1097/QAI.0000000000000347.

PMID:
25230291
19.

Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.

Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT.

AIDS. 2006 May 12;20(8):1171-9.

PMID:
16691069
20.

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group..

Arch Intern Med. 2002 Oct 14;162(18):2125-32.

PMID:
12374521

Supplemental Content

Support Center